We are featured in a webinar hosted by our partner BioIndustry Association UK.
China's biotech sector is growing more and more, and will continue to do so in the coming years. It is thus important to acknowledge this market as a full contender internationally.
The COVID-19 pandemic has only accelerated this process, with increasing investment tendencies into the Chinese biotech sector and vice versa.
Yet this comes with a few challenges for the Western companies, such as travel restrictions, cultural differences and geopolitical tensions.
Our external advisor is holding a short speech about working with Chinese biotech investors at this webinar held by our partner BioIndustry Association UK.
Want to learn more? Click here.